Is Suven Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Suven Pharmaceuticals pays dividends. Last time was Sunday 2nd of October 2022 where the investors holding the stock on Friday 9th of September 2022 were paid INR5 per share. Over the last 5 times between 2021 and 2022, Suven Pharmaceuticals has paid INR10 with an average of INR2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Suven Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of March 2020 when the price was INR168.52, you would have made a profit of INR1 031.63 per share or 612.15%
Yes, the average daily trading liquidity for Suven Pharmaceuticals is INR600 267 thousand. You should therefore be able to get in and out of your positions relatively fast.
Suven Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 1.51, the company's ability to pay off the debt is good. Suven Pharmaceuticals has a very good net profit margin of 28.56% and should have very high tolerances against inflation.
We have calculated the inflation risk for Suven Pharmaceuticals to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.